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In Brief
Garcia De Las Bayonas et al. investigate
the spatial control of Rho1 signaling that
drives contractility during epithelial
morphogenesis. They identify two
RhoGEFs, which independently activate
Rho1 at the medio-apical and junctional
compartments in intercalating cells. This
process requires upstream control by
distinct heterotrimeric G proteins.5
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Small RhoGTPases direct cell shape changes
and movements during tissue morphogenesis.
Their activities are tightly regulated in space and
time to specify the desired pattern of actomyosin
contractility that supports tissue morphogenesis.
This is expected to stem from polarized surface
stimuli and from polarized signaling processing
inside cells. We examined this general problem
in the context of cell intercalation that drives
extension of the Drosophila ectoderm. In the
ectoderm, G protein-coupled receptors (GPCRs)
and their downstream heterotrimeric G proteins
(Ga and Gbg) activate Rho1 both medial-apically,
where it exhibits pulsed dynamics, and at junc-
tions, where its activity is planar polarized. How-
ever, the mechanisms responsible for polarizing
Rho1 activity are unclear. We report that distinct
guanine exchange factors (GEFs) activate Rho1
in these two cellular compartments. RhoGEF2
acts uniquely to activate medial-apical Rho1
but is recruited both medial-apically and at junc-
tions by Ga12/13-GTP, also called Concertina (Cta)
in Drosophila. On the other hand, Dp114RhoGEF
(Dp114), a newly characterized RhoGEF, is required
for cell intercalation in the extending ectoderm,
where it activates Rho1 specifically at junctions.
Its localization is restricted to adherens junctions
and is under Gb13F/Gg1 control. Furthermore,
Gb13F/Gg1 activates junctional Rho1 and exerts
quantitative control over planar polarization of
Rho1. Finally, we found that Dp114RhoGEF is
absent in the mesoderm, arguing for a tissue-
specific control over junctional Rho1 activity. These
results clarify the mechanisms of polarization of
Rho1 activity in different cellular compartments
and reveal that distinct GEFs are sensitive tun-
ing parameters of cell contractility in remodeling
epithelia.3370 Current Biology 29, 3370–3385, October 21, 2019 ª 2019 The A
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Contractile actomyosin networks power cell shape changes
during tissue morphogenesis [1–3]. By pulling on actin fila-
ments anchored to E-cadherin complexes at adherens junc-
tions, non-muscle myosin-II (Myo-II) motors generate tensile
forces whose amplitude and orientation determine the nature
of cell- and tissue level-deformation [4–8]. Consequently, spe-
cific cortical Myo-II patterns predict specific cell shape
changes underlying tissue dynamics [9, 10]. During Drosophila
embryogenesis, apical constriction of cells underlies meso-
derm invagination [11, 12]. Apical constriction is driven by a
strictly medial-apical pool of Myo-II [13]. In contrast, during
elongation of the ventro-lateral ectoderm (also called germ-
band extension), cells intercalate as a consequence of a
polarized shrinkage of dorso-ventral interfaces or ‘‘vertical
junctions’’ [14–16]. This process depends on both a medial-
apical pulsatile Myo-II pool and a planar-polarized junctional
Myo-II pool to remodel cell interfaces during tissue extension
[15–17].
The small guanosine triphosphatase (GTPase) Rho1 is a chief
regulator of actomyosin networks in these developmental con-
texts [18–20], though Rac1 can also activate actin in epithelial
cells [21]. Rho1 cycles between an inactive GDP-bound confor-
mation and an active GTP-bound form. Rho1-GTP binds to
and thereby activates the kinase Rok, which in turn phosphory-
lates non-muscle Myo-II regulatory light chain (MRLC; Sqh in
Drosophila). This promotes assembly of Myo-II minifilaments
on actin filaments and induces contractility of actomyosin
networks. Two families of proteins regulate Rho cycling: Rho
guanine nucleotide exchange factors (RhoGEFs), which pro-
mote the exchange of GDP to active GTP-bound form of
Rho1 and Rho GTPase-activating proteins (RhoGAPs) that
inactivate Rho1 by promoting GTP hydrolysis to GDP [22].
Recent work has explored the contribution of specific GEFs
and GAPs during tissue invagination [23–25]. In the meso-
derm, apically localized RhoGEF2, the Drosophila ortholog of
the mammalian RH-RhoGEFs subfamily (p115RhoGEF/PDZ-
RhoGEF/LARG) [26–28], and the RhoGAP Cumberland tune
and restrict Rho1 signaling to the apical cell cortex [24]. How
Rho1 activity and therefore the Myo-II activity patterns are
controlled during cell intercalation where Rho1 is active both
medial-apically and at junctions remains unclear.uthors. Published by Elsevier Ltd.
creativecommons.org/licenses/by-nc-nd/4.0/).
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The Rho1-Rok core pathway activates both medial-apical and
junctional Myo-II in the ectoderm [18, 19]. Activation of Rho1
occursviadifferentmolecularmechanisms in thesedistinctcellular
compartments downstream of G protein-coupled receptors
(GPCRs) and their associated heterotrimeric G proteins [29].
Fog, a GPCR ligand initially reported for its function during apical
constriction in themesoderm [30–32], is also required for cell inter-
calation in the ectoderm [29]. It is thus a general regulator of
medial-apical Rho1 activation in the embryo, mediated by
Ga12/13/Cta and RhoGEF2. In the Drosophila embryo, the Fog-
Ga12/13/Cta-RhoGEF2 signaling module specifically controls
medial-apical Rho1 activity. The secreted Fog ligand binds to
GPCRs Smog andMist, whoseGEF activity catalyzes the dissoci-
ation of active Ga12/13/Cta-GTP from Gbg [29, 33]. Free Ga12/13/
Cta-GTP then binds to RhoGEF2 (inferred from RhoGEF2
mammalian orthologs) [28], which in turn activates Rho1, Rok,
and Myo-II at the apical membrane. In the mesoderm, apical tar-
geting of RhoGEF2 activity is driven by both active Ga12/13/Cta
and enhanced by the mesoderm-specific apical transmembrane
protein T48, which binds the PDZ domain of RhoGEF2 [34].
Whether Ga12/13/Cta is sufficient to localize RhoGEF2 activity
medial-apically in the ectoderm, where T48 is not expressed, is
unknown.
A separate biochemical module was hypothesized to control
and polarize junctional Rho1 independently in the ectoderm,
but the underlying molecular mechanisms remain unclear.
The pair-rule genes even-skipped (eve) and runt were the first
upstream regulators of planar polarized junctional Myo-II iden-
tified in the ectoderm [14, 35]. The Toll receptors (Toll2/6/8) are
transmembrane proteins whose expression in stripes is regu-
lated by Eve and Runt and who are essential for the polariza-
tion of Myo-II [36]. However, the molecular mechanisms linking
Tolls to Rho1 activation remain uncharacterized. The GPCR
Smog and the two heterotrimeric G protein subunits Gb13F/
Gg1 are involved in the tuning of Rho1 activity at ectodermal
junctions [29]. However, in the absence of a direct junctional
Rho1 activator, e.g., a specific RhoGEF, it is difficult to under-
stand how these upstream regulators polarize the GTPase
activity. In this study, we aim to dissect the spatial and tempo-
ral control of both medial-apical and junctional Rho1 activity in
the ectoderm.Figure 1. RhoGEF2 Activates Medial-Apical, but Not Junctional, Rho1
(A) Apical (0 mm) and junctional (1.5 mm) confocal z sections of ventro-lateral ec
8 min after the onset of cephalic furrow formation. White arrowheads show plana
(B) 7 mm projections of confocal acquisitions in both control and RhoGEF2 shRN
(C and D) Quantifications of mean medial-apical Rho1-GTP and mean junctional
GTP is decreased in the RhoGEF2 knockdown condition while junctional Rho1-G
(E) Top panels: apical (0 mm), junctional (2 mm), and lateral (8 and 12 mm) confocal
expressingMyo-II::mCherry and a-catenin::YFP, a junctional marker. Medial-apica
condition (white arrowheads). Although half of the RhoGEF2 germline clone em
apical levels, suggesting thatmaternally loaded RhoGEF2mainly controls the proc
and adherens junction distribution in both control and RhoGEF2 mutant ectoder
(F) Stack-focused image of control embryos (from 2 to 6 mm below apical mem
membrane) expressing Myo-II::GFP. Note that the planar-polarized Myo-II cable
(G) Myo-II amplitude of polarity at junctions in control and RhoGEF2 germline clone
conditions. The weak values of junctional Myo-II polarity measured in this experim
of the image.
Scale bars represent 5 mm. Means ± SEM between images are shown. Statistica
(ns), p > 0.05; *p < 0.05; **p < 0.01. All the panels have the same orientation: dor
See also Figures S1, S4, and S7 and Video S1.
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RhoGEF2 Controls Medial-Apical Rho1 Activity in the
Ectoderm
We used a Rho1-GTP biosensor that consists of a fusion pro-
tein between mEGFP (A206K monomeric EGFP) and the Rho-
binding domain (RBD) of anillin, which binds selectively to
active Rho1-GTP (Ani-RBD::GFP) [19] in the ectoderm. Ani-
RBD::GFP localization shows that active Rho1 is present
both medial-apically (Figure 1A, top panel right) and at adhe-
rens junctions (Figure 1A, bottom panel right), where it is planar
polarized (white arrowheads) as previously reported [19].
Importantly, the Rho1 activity pattern is not a consequence
of a differential subcellular enrichment in Rho1 protein. Indeed,
Rho1 is uniformly distributed along cell membrane in contrast
to the planar polarized Rho1-GTP biosensor (Figures S1A–
S1C). Hence, Rho1 regulators spatially control Rho1 activity
in this tissue. RhoGEF2 is a major activator of the medial-apical
Myo-II pool, but not the junctional pool in the ectoderm [29].
Therefore, we first asked whether medial-apical Rho1 activity
is specifically decreased upon RhoGEF2 knockdown. The
Rho1-GTP biosensor was analyzed in embryos expressing
short hairpin RNA (shRNA) against RhoGEF2 driven by mater-
nally supplied Gal4 (mata-Gal-VP16). We found that Rho1-GTP
was indeed decreased apically but strikingly preserved at junc-
tions (Figures 1B–1D; Video S1), consistent with the specific
regulation of medial-apical Myo-II by RhoGEF2 previously
described [29].
These shRNA studies could not rule out a residual RhoGEF2
population signaling at junctions. Therefore, we generated
RhoGEF2 maternal and zygotic mutants with germline clones
using a null allele for RhoGEF2, DRhoGEF2l(2)04291 [37], and
observed a complete loss of medial-apical Myo-II together
with an expanded cell surface area (Figure 1E). Interestingly,
junctional Myo-II persisted in RhoGEF2 mutant embryos and
its planar polarity was not affected (Figures 1F and 1G). Adhe-
rens junctions were also found deeper in the tissue relative to
wild-type junctions, consistent with a role of apical contractility
in the positioning of apical junctions [31, 38]. Thus, loss of
RhoGEF2 affects medial-apical, but not junctional, Rho1
signaling. Overall, in the ectoderm, RhoGEF2 is specificallyin the Ectoderm
todermal cells from embryos expressing Myo-II::mCherry and Ani-RBD::GFP,
r-polarized Myo-II and Rho1-GTP at vertical junctions.
A embryos expressing Ani-RBD::GFP.
Rho1-GTP intensities in control and RhoGEF2 shRNA embryos. Medial Rho1-
TP intensity is unchanged compared to control.
z sections of ectodermal cells in control and RhoGEF2 germline clone embryos
lMyo-II is lost inmutant embryos, andMyo-II is still detected at junctions in this
bryos express RhoGEF2 zygotically, no rescue has been observed for Myo-II
ess in awild-type embryo at this stage. Bottompanel: schematic view ofMyo-II
mal cells is shown.
brane) and RhoGEF2 germline clone embryos (from 8 to 12 mm below apical
s are still detected in RhoGEF2 germline clone.
. No difference in junctional Myo-II planar polarity is observed between the two
ent are due to an absence background subtraction during the post-processing
l significance has been calculated using Mann-Whitney U test. Not significant
sal at the top and anterior to the left.
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Figure 2. Ga12/13/Cta-GTP and Microtubules Control RhoGEF2 Enrichment at Cell Membrane in the Ectoderm
(A) Apical (0 mm), junctional (1.5 mm), and lateral (3.5 mm) z sections of ectoderm tissue co-expressing Myo-II::mCherry and GFP::RhoGEF2. Middle right panel,
bottom left corner: a close up of a cell showing GFP::RhoGEF2 « comets » is shown (yellow arrowheads)
(B) Confocal z section of an ectodermal cell co-expressing RhoGEF2::RFP and EB1::GFP (1 z plan, 2 mm below the apical membrane). Both EB1 and RhoGEF2 «
comets » co-localize; a slight spatial shift is observed between the two signals due to the acquisition condition (sequential acquisition).
(C) Apical (0 mm), junctional (1.5 mm), and lateral (3.5 mm) z sections of ectoderm tissue expressing GFP-RhoGEF2 in control, Ga12/13/Cta shRNA, and Ga12/13/
CtaQ303L++ embryos. Note that the brightness of the GFP-RhoGEF2 signal has been artificially decreased in the Ga12/13/Cta
Q303L++ panels for better
visualization.
(D and E) Quantifications of mean medial-apical and junctional GFP::RhoGEF2 intensities in control, Ga12/13/Cta shRNA, and Ga12/13/Cta
Q303L++ embryos. n,
number of embryos. Medial and junctional GFP::RhoGEF2 intensities are decreased in Ga12/13/Cta shRNA embryos but are increased in Ga12/13/Cta Q303L++
embryos compared to control.
(F) Total GFP::RhoGEF2 cortical levels normalized to the apical junctional intensities (2 mm below the apical membrane).
(legend continued on next page)
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required for Rho1 medial-apical activation, but not for junctional
activation and planar polarization.
Regulation of RhoGEF2 Localization and Activity in the
Ectoderm
The spatial distribution of Rho1 signaling could stem from spe-
cific control over the localization and/or activity of upstream
Rho1 regulators [23, 24]. Therefore, we analyzed RhoGEF2
localization in the ectoderm by imaging embryos expressing
RhoGEF2::GFP [24], whose expression rescues early embry-
onic phenotypes in RhoGEF2 mutants, and Myo-II::mCherry.
RhoGEF2 was enriched both apically and at cell junctions (Fig-
ure 2A), in agreement with previous reports [24, 39]. Addition-
ally, we detected a highly dynamic pool of RhoGEF2 «
comets » in the cytoplasm (Figure 2A, middle right panel, yellow
arrowheads), consistent with the observation that RhoGEF2 lo-
calizes at microtubule growing (plus) ends in S2 culture cells
[40]. To test this further in vivo, we analyzed embryos co-ex-
pressing RhoGEF2::RFP and GFP-tagged EB1, a microtubule
plus end tracking protein, and found that indeed RhoGEF2::RFP
co-localizes with EB1::GFP comets (Figure 2B; Video S2). The
much broader spatial distribution of RhoGEF2 with respect to
where RhoGEF2 is specifically required for Rho1 activation led
us to ask whether RhoGEF2 activity is spatially segregated in
the ectoderm.
Ga12/13/Cta and themembrane anchor T48 promote RhoGEF2
activation at the cell membrane inDrosophila uponGPCR activa-
tion [34, 40]. Both regulators cooperate to recruit RhoGEF2 to the
apical membrane in the mesoderm, where it activates Rho1
signaling. T48 anchors RhoGEF2 via a direct PDZ domain inter-
action. By analogy to its mammalian homolog p115RhoGEF,
RhoGEF2 is thought to bind to active Ga12/13/Cta via its N-termi-
nal RH domain. A conformational change then dislodges the
autoinhibitory N-terminal tail of the RhoGEF from its DH-PH do-
mains, making them accessible for binding to Rho1 and mem-
brane lipids [28]. Although this allosteric regulation by active
Ga12/13/Cta is sufficient to increase p115RhoGEF binding to
the membrane, it is not clear whether a full activation of the
RhoGEF requires additional control. T48 is not expressed in
the ectoderm [34] and therefore cannot account for RhoGEF2
activity at the apical membrane, though T48 overexpression in
the ectoderm can increase apical Myo-II activation (data not
shown) similar to RhoGEF2 overexpression [29]. We previously
showed that the Ga12/13/Cta-dependent increase of medial-api-
cal Myo-II is abolished upon RhoGEF2 knockdown in the lateral
ectoderm, indicating that RhoGEF2 transduces the signal down-
stream of Ga12/13/Cta [29]. Therefore, Ga12/13/Cta is a strong
candidate for controlling RhoGEF2 localization and activity in
the ectoderm. We examined RhoGEF2 localization in Ga12/13/
Cta-depleted embryos and in embryos expressing constitutively
active Ga12/13/Cta, Ga12/13/Cta
Q303L (a mutant that mimics
the GTP-bound state). Apical and junctional RhoGEF2 levels(G) Confocal Z section of an ectodermal cell expressing GFP::RhoGEF2 in co
GFP::RhoGEF2 « comets » (yellow arrowheads) are absent from Ga12/13/Cta
Q30
(H) Confocal cross-section of an ectodermal cell (1 mm below apical membrane)
Scale bars represent 5 mm. Means ± SEM between images are shown. Statistical
0.05; **p < 0.01. All the panels have the same orientation: dorsal at the top and a
See also Figures S2 and S7 and Videos S2 and S3.
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decreased (Figures 2D and 2E). This shows that Ga12/13/Cta con-
tributes to localizing RhoGEF2 in both compartments. Strikingly,
in Ga12/13/ Cta
Q303L embryos, RhoGEF2 was strongly enriched
everywhere at the cell surface, namely the apical membrane,
at junctions and along the lateral cell surface (Figures 2C–2E).
In contrast, RhoGEF2 « comets » were completely absent from
the cytoplasm in this condition (Figure 2G, yellow arrowheads;
Video S3) and EB1 comets were still present as in controls (Fig-
ure 2H). This suggests that Ga12/13/Cta-GTP promotes RhoGEF2
re-localization from microtubule growing ends to the cell mem-
brane upon GPCR activation, as reported in S2 cells [40]. We
further tested whether microtubules sequester RhoGEF2 and
thereby limit RhoGEF2 membrane recruitment and signaling.
Microtubule depolymerization following injection of colcemid
caused germ-band extension defects (Figures S2A and S2B)
and a medial-apical increase in Myo-II activation together with
a decrease in junctional Myo-II (Figures S2C–S2E). The medial-
apical phenotypewas similar to RhoGEF2 or Ga12/13/Cta overex-
pression [29], arguing that microtubules sequester and thereby
limit RhoGEF2 signaling medial-apically. Note that, although
medial-apical Rho1-GTP levels increased in Ga12/13/Cta
Q303L-
expressing embryos, they were unchanged at junctions (Figures
S2E–S2G), consistent with the previous report showing that only
medial-apical Myo-II was affected in such conditions [29]. Thus,
although active Ga12/13/Cta shifts RhoGEF2 distribution from
microtubule plus ends to both the medial-apical membrane
and cell junctions in the wild-type and in overexpression condi-
tions, RhoGEF2 signaling is consistently restricted to the apical
membrane.
Identification of a New RhoGEF Involved in Tissue
Extension
The striking apical specificity of RhoGEF2 indicates that
other RhoGEF(s) activate junctional Rho1 in the ectoderm.
We screened all 26 predicted Drosophila RhoGEFs for defects
in germ-band extension by expressing shRNA maternally
and zygotically. Knockdown of the maternal contribution was
crucial in such experiments, as a strong maternal mRNA
loading is observed for a large number of RhoGEFs in the
embryo (modENCODE_mRNA-seq; Flybase) [41]. Knockdown
of CG10188 (verified at the mRNA and protein levels; Figures
S3A and S3B) slowed germ-band extension (Figures 3A and
3B). Notably, intercalation events (also called T1 events), which
underlie tissue extension [15, 42], were significantly decreased
in CG10188 shRNA-expressing embryos (Figures 3C and 3D;
Video S4). Severe developmental defects were also observed
at later stages, such as the absence of germ-band retraction
and the occurrence of cell delamination, resulting in a fully
penetrant embryonic lethality (data not shown). We designed a
transgene that ubiquitously expresses a modified form of the
CG10188 mRNA immune to targeting by the shRNA, althoughntrol and Ga12/13/Cta
Q303L++ embryos (2 mm below the apical membrane).
3L++ embryos.
expressing EB1::GFP in control and Ga12/13/Cta
Q303L++ embryos.
significance has been calculated using Mann-Whitney U test. ns, p > 0.05; *p <
nterior to the left.
AC
E F
B
D
Figure 3. A New RhoGEF Controls Cell Intercalation during Germ-Band Extension
(A) Lateral view of a control and a CG10188 shRNA-expressing embryo at the onset (t = 0 min) of germ-band extension (GBE) and 40 min later. The dotted lines
mark the distance between the pole cells and the posterior side of the embryos 40 min after the onset of GBE.
(B) Quantification of the rate of germ-band extension in control and CG10188 shRNA embryos. A significant difference was observed in CG10188 shRNA
embryos (Kolmogorov-Smirnov two-sample test). p value for Kolmogorov-Smirnov two-sample test is indicated in the panel. p > 0.01.
(C) Top panels: a representative view of the extending ventro-lateral ectoderm in control and CG10188 shRNA embryos expressing Utr::GFP. Bottom panels:
segmented view of the same embryos is shown. T1 transitions are depicted in green and red on the image.
(D) Cumulative sum of T1 transitions measured for control and CG10188 shRNA embryos over a period of 10 min.
(E) Percentage of embryos that hatched in control (n = 238/354 embryos), CG10188 shRNA (n = 0/243 embryos), and CG10188 shRNA, Sqh-cg10188wt shRNA
(n = 86/213 embryos) conditions. The egg-hatching percentage was determined as a measurement of embryo viability (STAR Methods). The fully penetrant
embryonic lethality observed in CG10188 shRNA embryos is rescued by the expression of the targeted gene refractory to the shRNA (Sqh-CG10188 shRNAR).
(legend continued on next page)
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with preserved codon usage (SqhPa-CG10188-shRNAR; STAR
Methods). This transgene rescued lethality in CG10188
shRNA-expressing embryos and proved the specificity of the
knockdown (Figure 3E). Overall, these results demonstrate a
requirement for CG10188 during germ-band extension.
CG10188 has not yet been functionally characterized in
Drosophila. From sequence and domain similarity, CG10188 is
the ortholog of the mammalian RhoGEF subfamily, including
p114RhoGEF, AKAP13, GEF-H1, and p190RhoGEF, who each
activate RhoA [43, 44] (Figure 3F). Based on their sequence
and function [45] compared with our data hereafter, we conclude
that p114RhoGEF is the closest mammalian ortholog of the
Drosophila CG10188, and we will now refer to CG10188 as
Dp114RhoGEF. Transcriptomic analyses reported a maternal
and zygotic expression of Dp114RhoGEF in the embryo, sug-
gesting that the protein could be present and active in the ecto-
derm [46, 47].
Dp114RhoGEF Activates Rho1 Signaling at Adherens
Junctions in the Ectoderm
To test whether Dp114RhoGEF controls Rho1 activity in the
ectoderm, we investigated the distribution of the Rho-GTP
biosensor in Dp114RhoGEF shRNA-expressing embryos. In
striking contrast to the RhoGEF2 knockdown, medial-apical
Rho1-GTP levels were unaffected, whereas junctional Rho1-
GTP was strongly decreased (Figures 4A–4C). The loss of active
junctional Rho1 suggested that junctional Myo-II might be
affected. Therefore, we analyzed Myo-II::mCherry in control
and Dp114RhoGEF shRNA embryos. Similar to Rho1-GTP, junc-
tional Myo-II was strongly reduced andmedial-apical Myo-II was
preserved (Figures 4D–4F and S3C; Video S5). Importantly, the
expression of the Dp114RhoGEF-shRNAR transgene in
Dp114RhoGEF shRNA embryos rescuedMyo-II junctional levels
(Figures S3D and S3E). We noticed that Myo-II persisted at cell
vertices in the Dp114RhoGEF knockdown (Figure 4D, bottom
right panel). Rho1-GTP is not detected at vertices in this condi-
tion (Figure 4A), which suggests either a redistribution of remain-
ing active Myo-II in this condition or that Myo-II could be
activated through different mechanisms in this compartment.
Last, compared to wild-type, E-cadherin levels were globally
reduced in Dp114RhoGEF knockdown embryos with a highly
discontinuous E-cadherin distribution at junctions (Figures
S3F–S3H). Similar E-cadherin defects have been observed
upon dominant-negative Rho1 expression and Rho1 inhibition
[18, 48, 49], consistent with the specificity of Dp114RhoGEF
for Rho1 signaling.
RhoGEF2 exhibits a dose-dependent effect on medial-apical
Rho1 signaling in that overexpression of RhoGEF2 is sufficient
to increase medial Rho1-GTPase and Myo-II activation [29, 50].
Therefore, we asked whether increasing Dp114RhoGEF expres-
sion levels could, symmetrically, increase Rho1 signaling at
junctions. The Dp114RhoGEF levels were increased by driving(F) Phylogenetic tree inferred from sequence similarity between the Drosophil
(UniProtKB: Q6ZSZ5-4), GEF-H1 (UniProtKB: Q92974-1), p190RhoGEF (UniProtK
collected from UniProt and clustered by multiple sequence alignment using Clust
characteristic of the Dbl-RhoGEFs and a coil-coiled (CC) motif in its C-terminal r
Scale bars represent 50 mm (A) and 15 mm (C). Error bars, SD for (B) and SEM fo
See also Figure S3 and Video S4.
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ubiquitous MRLC/Sqh promoter in Myo-II::mCherry embryos.
The result was unique and striking: Dp114RhoGEF overexpres-
sion led to a global Myo-II junctional increase relative to control
with no effect on medial-apical Myo-II (Figures 4G–4I; Video
S6). Myo-II was increased both at transverse (0–15; 63%
increase) and vertical junctions (75–90; 200% increase; Fig-
ure 4J), with a resulting modest (24%) increase in planar polarity
(Figure 4K). Thus, Dp114RhoGEF tunes Rho1 signaling in a dose-
dependent manner at junctions.
RhoGEF2 and Dp114RhoGEF show complementary spatial
restriction of activity on Rho1 signaling. We thus hypothesized
that a double knockdown of both RhoGEFs should abolish
total Rho1 activity in the ectoderm. Indeed, Rho1-GTP and
Myo-II were decreased both apically and at cell junctions in
this context (Figures S4A–S4F). Together, our data demonstrate
that Dp114RhoGEF is a key activator of Rho1 signaling at adhe-
rens junctions in the ectoderm. Moreover, RhoGEF2 and
Dp114RhoGEF have additive and non-redundant functions in
the ectoderm.
Dp114RhoGEF Mediates Gb13F/Gg1-Dependent
Junctional Rho1 Signaling
Given the critical function of Gb13F/Gg1 in the regulation of
medial-apical and junctional Myo-II pools [29], we examined its
link with Dp114RhoGEF at junctions. We first tested whether
Rho activity was dependent upon Gb13F/Gg1. We analyzed
the Rho1-GTP biosensor distribution in both Gb13F/Gg1 loss-
of-function (Gg1 germline clone) and gain-of-function (Gb13F/
Gg1 overexpression) conditions. Loss of Gg1 resulted in a
reduction of both junctional and medial-apical Rho1-GTP,
consistent with the overall reduction in Myo-II previously re-
ported [29] (Figures 5A–5C). Note that the medial-apical
decrease in Rho1 signaling does not imply direct Gb13F/Gg1
activity apically, as this is expected from the knownmechanisms
controlling heterotrimeric G protein activation. Indeed, the Gbg
subunit dimer is necessary to properly localize Ga at the mem-
brane and thereby to prime Ga to respond to GPCR GEF activity
[51–53]. Thus, Gb13F/Gg1 is required for Ga12/13/Cta activation
(Ga-GTP) downstream of GPCRs, such that loss of Gb13F/Gg1
also causes loss of Ga12/13/Cta activity.
We then overexpressed both Gb13F and Gg1 in embryos to
test a dose-dependent effect of these subunits on junctional
Rho1 signaling. Overexpression of either Gb13F or Gg1 alone
did not give any phenotype (data not shown), consistent with
studies showing that the individual Gb and Gg subunits can
neither be transported to the membrane individually nor bind to
or signal via their molecular effectors as monomers [54, 55]. In
contrast and remarkably, Gb13F/Gg1 co-expression resulted
in a specific enrichment in Rho1 activity at vertical junctions
(23% increase) compared to controls (Figure 5D). Consequently,
Rho1-GTP planar polarity was significantly increased (25%a CG10188 (Flybase: FBgn0032796) and its human orthologs p114RhoGEF
B: Q8N1W1-1), and AKAP13 (UniProtKB: Q12802-1). Human sequences were
alOmega (nj tree, no distance correction). CG10188 exhibits a DH-PH tandem
egion, known to be a dimerization domain in its mammalian counterparts.
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Figure 4. Dp114RhoGEF Activates Junctional Rho1 Signaling in the Ectoderm
(A) 4 mm z projection of confocal acquisition of control or Dp114RhoGEF shRNA embryos expressing Ani-RBD::GFP. Active Rho1 is specifically decreased at
junctions upon Dp114RhoGEF knockdown.
(B and C) Meanmedial-apical and junctional Rho1-GTP intensities in both control and Dp114RhoGEF shRNA embryos. Junctional Rho1-GTP is decreased in the
Dp114RhoGEF knock-down condition while medial Rho1-GTP intensity is unchanged compared to control.
(legend continued on next page)
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increase; Figure 5E). However, medial-apical Rho1 activity was
not significantly changed upon Gb13F/Gg1 co-expression, indi-
cating a different sensitivity to Gb13F/Gg1 levels in the apical
compared to the junctional compartments (Figure 5F). Note
that Ga12/13/Cta showed the opposite pattern (Figures S2E–
S2G). Myo-II::mCherry was next examined in Gb13F/Gg1-
overexpressing embryos (referred to as Gb13F/Gg1++). Consis-
tent with the previous data, we observed a specific increase of
Myo-II at vertical junctions (48% increase; Figures 5G and 5H;
Video S7), leading to a strong (2-fold) increase in Myo-II planar
polarity (Figure 5I). Medial-apical Myo-II levels were unchanged
in this condition (data not shown). Because Gb13F/Gg1 overex-
pression hyperpolarized Myo-II in all the ectodermal cells, the
strong parasegmental boundaries cables [56] observed in the
wild-type (yellow arrowheads in Figure 5G, left panel) were now
indistinguishable from the other vertical interfaces (orange arrow-
heads in Figure 5G, right panel). However, despite a clear effect
on junctional Myo-II, the rate of germ-band extension was not
affected upon Gb13F/Gg1 overexpression (data not shown).
Altogether, we uncovered a new role for Gb13F/Gg1 dimer,
which is involved quantitatively in the planar polarization of
Rho1 signaling at junctions. Therefore, both Gb13F/Gg1 and
Dp114RhoGEF regulate junctional Myo-II by quantitatively
tuning Rho1 activation at junctions.
These results suggested that Dp114RhoGEF might be genet-
ically epistatic to Gb13F/Gg1. Thus, we investigated Gb13F/Gg1
overexpression in conjunction with Dp114RhoGEF shRNA to
explore this relationship. To avoid any differential titration of
Gal4 effects, the number of UAS regulatory sequences was
equivalent in both the Gb13F/Gg1++ and the Gb13F/Gg1++,
Dp114RhoGEF shRNA embryos (STAR Methods). The polarized
increase in Myo-II at vertical junctions in Gb13F/Gg1++ embryos
was no longer observed in Gb13F/Gg1++, Dp114RhoGEF
shRNA embryos (Figure 6A), which were indistinguishable from
Dp114RhoGEF shRNA embryos alone (Figures 6B and 6C;
compare with Figures 4D, S3A, and S3B). Overall, these data
show that Dp114RhoGEF is crucial to mediate Gb13F/Gg1-
dependent Rho1 signaling at junctions.
Gb13F/Gg1 Regulates Dp114RhoGEF Junctional
Enrichment in the Ectoderm
The new genetic interaction between Gb13F/Gg1 and
Dp114RhoGEF led us to ask whether Gb13F/Gg1 subunits could(D) Confocal acquisitions of control and Dp114RhoGEF shRNA embryos express
part left panel for both conditions (the most apical z planes containing medial-a
II::mCherry signal in the close-up views).
(E and F) Quantifications of mean medial-apical and junctional Myo-II intensiti
decreased in Dp114RhoGEF knock-down embryos compared to control while m
(G) Myo-II::mCherry in control and Sqh-Dp114RhoGEF embryos (Dp114RhoGEF
(H and I) Mean medial-apical and junctional Myo-II intensities in control and Dp11
Myo-II intensity while junctional Myo-II intensity doubled in this condition compa
(J) Left panel: mean junctional intensity of Myo-II according to the angle of the junc
to the antero-posterior axis). Right panels: distributions of junctional Myo-II intens
Dp114RhoGEF++ embryos are shown. A significant difference was observed
Kolmogorov-Smirnov two-sample test in each comparison are indicated on the p
(K) Quantification of Myo-II amplitude of polarity in control and Dp114RhoGEF++ e
at vertical junctions to mean Myo-II intensity at transverse junctions.
Scale bars represent 5 mm. Means ± SEM are shown. Statistical significance has
See also Figures S3, S4, and S7 and Videos S5 and S6.
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sessed their respective subcellular distribution in vivo. Trans-
genic lines that express Dp114RhoGEF tagged with either N-ter-
minal or C-terminal GFP were generated (STAR Methods).
Embryos expressing GFP-tagged Dp114RhoGEF and Myo-
II::mCherry were imaged. We found that Dp114RhoGEF::GFP
localization was restricted to adherens junctions, where it forms
puncta in both N- and C-terminal GFP fusions (Figures 7A and
S5A). Remarkably, although expressed ubiquitously in the
embryo, Dp114RhoGEF::GFP was not detected at junctions in
the mesoderm (Figure 7B). It has been reported that Rho1
signaling in mesodermal cells is induced medial-apically and
absent from junctions [24]. Therefore, a mesoderm-specific
regulation is likely to block junctional Rho1 signaling in this tissue
via Dp114RhoGEF mRNA or protein degradation, because we
failed to detect any increase in cytoplasmic Dp114RhoGEF::GFP
signal in these cells (Figure 7B).
Planar-polarized Rho1 activity at ectodermal junctions could
be explained by a planar-polarized distribution of its direct
activator(s) in the ectoderm. To test this hypothesis, we next
compared junctional Dp114RhoGEF distribution with the distri-
bution of the non-polarized membrane protein GAP43 in the
ectoderm of the same embryos. No difference was observed
between Dp114RhoGEF and GAP43 amplitude of polarity (Fig-
ures S5B and S5C). Thus, Dp114RhoGEF localization alone
cannot account for the polarized Rho signaling at junctions.
Alternatively, Dp114RhoGEF activity could be polarized at
junctions. Considering the newly uncovered genetic interaction
between Dp114RhoGEF and Gb13F/Gg1 in the control of
junctional Rho1 signaling, we hypothesized that the heterotri-
meric G proteins could be upstreamactivators of Dp114RhoGEF.
Thus, the localization of Gb13F/Gg1 could instruct planar
polarization of Dp114RhoGEF activity. We generated anti-
bodies against two different peptides of Gb13F (STAR Methods)
and confirmed their specificity by western blot and immuno-
chemistry analyses (Figures S6A–S6C). Both antibodies revealed
an apical and junctional enrichment of Gb13F in the ectoderm
(Figure S6C). Furthermore, Gb13F co-localizes with both
Dp114RhoGEF and b-catenin at junctions (Figures 7C and S6D,
respectively), where it is not planar polarized (Figure S6E).
Finally, we asked whether Gb13F/Gg1 controls Dp114RhoGEF
enrichment at junctions. We looked at Dp114RhoGEF::GFP
signal in both gain (Gb13F/Gg1++) and loss of Gb13F/Gg1ing Myo-II::mCherry. A close up of a representative cell is shown in the bottom
pical Myo-II have been removed for a better visualization of junctional Myo-
es in both control and Dp114RhoGEF shRNA embryos. Junctional Myo-II is
edial Myo-II intensity is unaffected in this condition.
++).
4RhoGEF++ embryos. Dp114RhoGEF overexpression does not affect medial
red to control.
tions (junction angle; 0, parallel to the antero-posterior axis; 90, perpendicular
ity values at transverse (0–15) and vertical junctions (75–90) in control and
in both angular ranges (Kolmogorov-Smirnov two-sample test). p values for
lot. ns, not significant, p > 0.05.
mbryos. Amplitude of polarity is measured as the ratio of meanMyo-II intensity
been calculated using Mann-Whitney U test. ns, p > 0.05; *p < 0.05; **p < 0.01.
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Figure 5. Gb13F/Gg1 Activates and Polarizes Junctional Rho1 Signaling in the Ectoderm
(A) Apical (0 mm) and junctional (1.5 mm) confocal z sections of ventro-lateral ectodermal cells expressing Ani-RBD::GFP in control, Gg1 germline clone (Gg1),
and Gb13F/Gg1-overexpressing embryos (Gb13F/Gg1++).
(legend continued on next page)
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(Gb13F/Gg1). Dp114RhoGEF was decreased at junctions upon
Gg1 depletion (Figures 6D and 6E). Conversely, Gb13F/Gg1 over-
expression led to an increase in Dp114RhoGEF levels at junc-
tions, though strikingly without any gain in planar polarity (Figures
7F, 7G, and S6F), which contrasts with the gain in Rho1-GTP and
Myo-II planar polarity in this condition. Taken together, our data
show thatGb13F/Gg1 subunits are present at adherens junctions,
where they increase recruitment of Dp114RhoGEF, allowingRho1
to signal efficiently in this compartment.
DISCUSSION
Critical aspects of cell mechanics are governed by spatial-
temporal control over Rho1 activity during Drosophila embryo
morphogenesis. This work sheds new light on the mecha-
nisms underlying polarized Rho1 activation during intercala-
tion in the ectoderm. We found that Rho1 activity is driven
by two complementary RhoGEFs under spatial control of
distinct heterotrimeric G protein subunits (Figure S7). Notably,
we uncovered a regulatory module specific for junctional Rho1
activation.
We identified Dp114RhoGEF as a novel activator of junctional
Rho1 in the extending ectoderm. Hence, two RhoGEFs,
Dp114RhoGEF and RhoGEF2, coordinate independently the
modular Rho signaling during tissue extension of the ectoderm.
This has important implications, as it allows us to refine the na-
ture of the interconnection between the two pools of Myo-II in
this tissue. We showed previously that medial pulses of Myo-II
flow toward and merge with the Myo-II pool at vertical junctions
[17]. However, to what extent these ‘‘fusion’’ events contribute to
junctional Myo-II was unclear. In the present study, we geneti-
cally uncoupled the regulation of both pools of Myo-II and
showed that the loss of one pool does not compromise activa-
tion of Myo-II in the other. Indeed, junctional Myo-II levels and
planar polarity are not affected in RhoGEF2 shRNA embryos or
in RhoGEF2 germline clone where medial Myo-II is lost. This
rules out the possibility of medial pulses being the main source
of junctional Myo-II accumulation. Instead, we conclude that
actomyosin flow toward junctions contributes to junction
shrinkage because it serves a distinct and direct mechanical
function in junction remodeling rather than working by proxy by
fueling junctional Myo-II.(B and C) Mean medial-apical and junctional Rho1-GTP intensities in control and
Gg1 mutant compared to control embryos.
(D) Mean junctional intensity of Rho1-GTP according to the angle of the junction
(E) Rho1-GTP amplitude of polarity.
(F) Medial-apical Rho1-GTP intensities in control and Gb13F/Gg1++ embryos.
(G) Confocal acquisitions (4.5 mm projections) showing Myo-II::mCherry in contro
ment boundaries cables of Myo-II in a control embryo; orange arrowheads sh
expression).
(H) Left panel: mean junctional intensity of Myo-II::mCherry according to the angle
distributions of junctional Myo-II intensity values for transverse (0–15) and verti
mild statistical difference at the transverse junctions (Kolmogorov-Smirnov two
intensity values in Gb13F/Gg1++ embryos as compared to control. At vertical junc
of a global increase in Myo-II intensity values in Gb13F/Gg1++ embryos compa
indicated on the plot. ns, not significant, p > 0.05.
(I) Quantification of Myo-II amplitude of polarity in control and Gb13F/Gg1++ em
Scale bars represent 5 mm. Means ± SEM are shown. Statistical significance has
See also Figure S7 and Video S7.
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activation in distinct cellular compartments lends itself to differ-
ential quantitative regulation. The activation kinetics of these
different GEFs and nucleotide exchange catalytic efficiencies
are likely to differentially impact Rho1 activity and therefore
Myo-II activation at the junctional and medial-apical compart-
ments. For example, RhoGEF2 mammalian orthologs, LARG
and PDZ-RhoGEF, show a catalytic activity that is two orders
of magnitude higher as compared with the Dp114RhoGEF ortho-
logs subfamily [57]. This may help to establish specific contrac-
tile regimes of actomyosin in given subcellular compartments. It
is therefore important to tightly control RhoGEFs localization and
activity to ensure a proper quantitative activation of the down-
stream GTPase.
RhoGEF2 is a major regulator of medial-apical Rho1 activity
during Drosophila gastrulation [34, 37, 58]. Originally character-
ized in the invaginating mesoderm, we found that RhoGEF2
also activates Rho1 medial-apical activity in the elongating ecto-
derm. There, RhoGEF2 localizes both medial-apically and at
junctions where it is also planar polarized. Although RhoGEF2
and active Rho1 are both planar polarized at junctions, in
RhoGEF2 mutants, junctional Rho1-GTP is not affected and
ectopic recruitment of RhoGEF2 following expression of
Ga12/13
Q303L does not cause ectopic junctional Rho1-GTP accu-
mulation. Thus, RhoGEF2 localization at the membrane is not
strictly indicative of its activation status. Interestingly, Ga12/13/
Cta is necessary for RhoGEF2 to translocate from microtubules
plus ends to the plasma membrane where it signals. To date,
experimental evidence favor a model whereby the binding of
active Ga12/13/Cta to the RhoGEF in the vicinity of the cell mem-
brane triggers its conformational change and stabilizes it in an
open conformation able to bind to lipids via its PH domain and
signal at the plasma membrane [28]. There is no evidence that
Ga12/13/Cta-GTP actively destabilizes RhoGEF2-EB1 interac-
tion, but this is a formal possibility to be tested. Importantly,
Ga12/13/Cta alone does not account for the restricted activation
of Rho1 medial-apically.
We hypothesize that additional factors must regulate the
spatial distribution of RhoGEF2 activity. In principle, RhoGEF2
signaling activity could either be specifically induced medial-
apically independent of RhoGEF2 recruitment or RhoGEF2 could
be inhibited at junctions and laterally. Sequestration of inactiveGg1 embryos. Medial and junctional Rho1-GTP intensities are decreased in
s in control and Gb13F/Gg1++ embryos.
l and Gb13F/Gg1++ embryos (yellow arrowheads show two strong compart-
ow the ectopic supracellular cables of Myo-II induced by Gb13F/Gg1 over-
of the junctions in control and Gb13F/Gg1++ embryos. Right panels show the
cal junctions (75–90) in control and Gb13F/Gg1++ embryos. We observed a
-sample test; p < 0.05). This is explained by an increase in the lower Myo-II
tions, a strong statistical difference was observed (p < 107) as a consequence
red to control. p values for Kolmogorov-Smirnov test in each comparison are
bryos.
been calculated using Mann-Whitney U test. ns, p > 0.05; *p < 0.05; **p < 0.01.
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Figure 6. Dp114RhoGEF Mediates Gb13F/
Gg1 Signaling at Junctions
(A) Confocal acquisitions of Myo-II::mCherry in the
ventro-lateral ectoderm of control, Gb13F/Gg1++,
and Gb13F/Gg1++, Dp114RhoGEF shRNA em-
bryos. The increase of Myo-II at vertical junctions
observed in Gb13F/Gg1++ embryos is lost when
Dp114RhoGEF shRNA is also expressed in the
background.
(B) Mean junctional intensity of Myo-II::mCherry
according to the angle of the junctions in control,
Gb13F/Gg1++ embryos, and Gb13F/Gg1++,
Dp114RhoGEF shRNA embryos.
(C) Amplitude of polarity of junctional Myo-II::
mCherry in control, Gb13F/Gg1++ embryos, and
Gb13F/Gg1++, Dp114RhoGEF shRNA embryos.
Although Myo-II planar polarity increases upon
Gb13F/Gg1 overexpression compared to control
embryos, co-expression of Gb13F/Gg1 together
with Dp114RhoGEF shRNA reduces Myo-II planar
polarity, similar to Dp114RhoGEF shRNA embryos
alone.
Scale bars represent 5 mm. Means ± SEM are
shown. Statistical significance has been calcu-
lated usingMann-Whitney U test. ns, p > 0.05; *p <
0.05; **p < 0.01.
See also Figure S7.RhoGEFs at cell junctions has been reported previously in
mammalian cell cultures [59, 60], suggesting that such mecha-
nism could be evolutionary conserved. Phosphorylation can
control the activity of the RH-RhoGEFs subfamily [61, 62]. There-
fore, phosphorylation could promote activation or inhibition of
RhoGEF2 activity in specific subcellular compartments in the
ectoderm. RhoGEF2 is reported to be phosphorylated in the gas-
trulating embryo [63].
Complementary to RhoGEF2, Dp114RhoGEF activates junc-
tional Rho1 in the ectoderm. Dp114RhoGEF strictly localizes at
junctions (Figure 7A), providing a direct explanation for its junc-
tional-specific effect. We showed that Gb13F/Gg1 is also en-
riched at adherens junctions, where it controls Dp114RhoGEF
junctional recruitment together with additional upstream regula-
tors (Figures 7D–7G). Therefore, we suggest that Gb13F/Gg1-
dependent tuning of junctional Rho1 activation could be
achieved through its ability to concentrate the GEF at junctions.
Gb/Gg-dependent regulation of RhoGEFs has been described in
mammals [64, 65]. One study proposes that mammalian
p114RhoGEF may bind and be activated by Gb1/Gg2 [64]. Inter-
estingly, recent work demonstrates that Ga12 can also recruit
p114RhoGEF at cell junctions under mechanical stress in
mammalian cell cultures where it promotes RhoA signaling
[66]. However, the region of mammalian p114RhoGEF that binds
to Ga12 is absent in invertebrate RhoGEFs [67]. How Gb13F/Gg1
controls Dp114RhoGEF at junctions in the Drosophila embryo
remains an open question. A recent study reports that
Dp114RhoGEF localizes at adherens junctions in the Drosophilatw
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including interactions with Baz/Par3 and
the Crumbs complex [68]. Therefore,
investigating a possible connection be-een Gb13F/Gg1 signaling and Baz/Crumbs should help deci-
er the mechanisms of Dp114RhoGEF localization.
Importantly, neither Gb13F/Gg1 nor Dp114RhoGEF are them-
lves planar polarized at junctions. Hence, their distribution
ne cannot explain polarized Rho1 activity at junctions. Strik-
ly, we found that an increase in Gb13F/Gg1 dimers hyperpo-
izes Rho1 activity and Myo-II at vertical junctions (Figure 5H).
13F/Gg1 overexpression also leads to an overall increase in
114RhoGEF levels at junctions, although Dp114RhoGEF is
t planar polarized in this condition. This indicates that recruit-
ent at the plasma membrane and activation of Dp114RhoGEF
e independently regulated, similar to RhoGEF2. In contrast,
114RhoGEF overexpression increases Myo-II at both
nsverse and vertical junctions, although a slightly stronger
cumulation is observed at vertical junctions (Figures 4J and
). Therefore, although Dp114RhoGEF junctional levels are
reased in both experiments, only Gb13F/Gg1 overexpres-
n leads to an increased planar polarization of Rho1-GTP
d Myo-II at vertical junctions. This points to a key role for
13F/Gg1 subunits in the planar-polarization process associ-
ed with but independent from the sole recruitment of
114RhoGEF at junctions. In principle, Gb13F/Gg1 could
as junctional Rho1 signaling either by promoting its activation
vertical junctions or by inhibiting it at transverse junctions
.g., RhoGAP polarized activation). Gb13F/Gg1 could also con-
l active Rho1 distribution independent of its activation. For
tance, a scaffolding protein binding to Rho1-GTP at junctions
uld be polarized byGb13F/Gg1 to bias Rho1-GTP distributiongy 29, 3370–3385, October 21, 2019 3381
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Figure 7. Dp114RhoGEF Localizes at Adherens Junctions under Control of Gb13F/Gg1 in the Ectoderm
(A) Apical (0 mm), junctional (1.5 mm), and lateral (3.5 mm) confocal z sections of ventro-lateral ectodermal cells from embryos co-expressing Myo-II::mCherry and
Dp114RhoGEF::GFP. Dp114RhoGEF localizes exclusively at junctions together with junctional Myo-II.
(B) Confocal acquisitions of ectodermal cells (top panels) andmesodermal cells (bottom panels) in embryos expressing Dp114RhoGEF::GFP andGAP43::Cherry.
Although Dp114RhoGEF::GFP is detected at junctions in the ectoderm, Dp114RhoGEF::GFP signal is absent from the invaginating mesoderm.
(C) Anti-Dp114RhoGEF::GFP and anti-Gb13F stainings in ectodermal cells showing the enrichment of both Dp114RhoGEF and Gb13F at adherens junctions
(1.5 mm single plane).
(D and F) Confocal z projections of ectodermal cells expressing Dp114RhoGEF::GFP in control, Gg1, and Gb13F/Gg1++ embryos. Junctional Dp114RhoGEF is
decreased in Gg1 germline clones and increased upon Gb13F/Gg1 overexpression.
(E and G) Quantifications of mean junctional Dp114RhoGEF::GFP intensities in control, Gg1, and Gb13F/Gg1++ embryos. Junctional Dp114RhoGEF::GFP
intensity is decreased in Gg1 mutant embryos and is increased in Gb13F/Gg1++ embryos compared to control.
Scale bars represent 5 mm. Means ± SEM are shown. Statistical significance has been calculated using Mann-Whitney U test. ns, p > 0.05; *p < 0.05; **p < 0.01.
See also Figures S5–S7.
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downstream of its activation. Anillin, a Rho1-GTP anchor known
to stabilize Rho1 signaling at cell junctions [69], is a potential
candidate in the ectoderm. Last, Toll receptors control Myo-II
planar polarity in the ectoderm [36]. Whether Gb13F/Gg1 and
Tolls are part of the same signaling pathway is an important
point yet to address in the future.
Finally, our study sheds light on new regulatory differences un-
derlying tissue invagination and tissue extension. Here, we found
that Dp114RhoGEF localizes at junctions in the ectoderm, where
it activates Rho1 and Myo-II. In contrast, maternally and
zygotically supplied Dp114RhoGEF::GFP is not detected at
junctions in themesoderm.We see little if any cytoplasmic signal
in this condition, suggesting that Dp114RhoGEF::GFP could be
degraded in these cells. Thus, repression of Dp114RhoGEF pro-
tein in the mesoderm could be an important mechanism for cell
apical constriction and proper tissue invagination. Of interest,
Rho1 signaling is absent at junctions in the mesoderm [20].
Therefore, it is tempting to suggest that the absence of
Dp114RhoGEF at junction in the mesoderm accounts for cells’
inability to activate Rho1 in this compartment. Importantly, the
GPCR Smog and Gb13F/Gg1 subunits, found to control junc-
tional Rho1 in the ectoderm, are common to both tissues [29].
Dp114RhoGEF differential expression and/or subcellular locali-
zation could be a key element to bias signaling toward junctional
compartment in the ectoderm.
Cell contractility necessitates activation of the Rho1-Rock-
MyoII core pathway. During epithelial morphogenesis, tissue-
and cell-specific regulation of Rho1 signaling requires the diversi-
fication of Rho1 regulators, in particular RhoGEFs, as shown in
this study, and RhoGAPs. Some of them are tissue specific
with given subcellular localizations and activation mechanisms.
The identification of signalingmodules, namely Ga12/13-RhoGEF2
and Gb13F/Gg1-Dp114RhoGEF, provides a simple mechanistic
framework for explaining how tissue-specific modulators control
Rho1 activity in a given subcellular compartment in a given cell
type. Therefore, we suggest that the variation of (1) ligands,
GPCRs, and associated heterotrimeric G proteins and (2) types
of RhoGEFs and RhoGAPs as well as their combination, activa-
tion, and localization by respective co-factors underlies the
context-specific control of Rho1 signaling during tissue morpho-
genesis. Howdevelopmental patterning signals ultimately control
Rho regulators is an exciting area for future investigations.STAR+METHODS
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BL-80361
D.melanogaster: y1 sc v1;;UAS-RhoGEF2 shRNA Bloomington Drosophila stock center BL-34643
D.melanogaster: ;{mata4-GAL-VP16},Sqh-GFP::
utABD,Sqh-Sqh::mKate;
This paper N/A
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
D.melanogaster: UASt-CtaQ303L/TM3 Gift from Naoyuki Fuse [73]
D.melanogaster: hsflp22; FRTG13 RhoGEF2l(2)04291/Cyo; Combinant from this laboratory, FRTG13
RhoGEF2l(2)04291 is a Gift from U. H€acker
[37, 39]
D.melanogaster: UASp-GAP43::mCherry, nanos-
Gal4/TM6Tb
Gift from Manos Mavrakis N/A
D.melanogaster: y1 sc v1; UAS-Yellow shRNA /CyO Bloomington Drosophila stock center BL-64527
D.melanogaster: endo-a-Catenin::YFP Cambridge Protein Trap Insertion line CPTI-002516
DGRC: 115551
D.melanogaster: y1 v1;UAS-Cta shRNA Bloomington Drosophila stock center BL-51848
D.melanogaster: w;SP/Cyo;UASp-RFP-RhoGEF2
[wt]/TM3, Sb hb-lacZ{ry+}
Gift from Jo¨rg Großhans [75]
D.melanogaster: (y),w ; 67-Gal4, UAS-EB1::GFP/CyO,
ftz-lacZ
Gift from Damian Brunner [76]
Recombinant DNA
Plasmid DNA-Casper SqhPa- Dp114RhoGEF This paper N/A
Plasmid DNA-Casper SqhPa- mEGFP::Dp114RhoGEF This paper N/A
Plasmid DNA-Casper SqhPa- Dp114RhoGEF:: mEGFP This paper N/A
Plasmid DNA-Casper SqhPa- Dp114RhoGEF-shRNAR This paper N/A
Plasmid DNA-Casper SqhPa- mEGFP::Dp114RhoGEF-
shRNAR
This paper N/A
Software and Algorithms
FlyBase [42] https://flybase.org/
ImageJ 1.x [77] https://imagej.net/Downloads
Fiji [78] https://imagej.net/Fiji/Downloads
Tissue Analyzer [79] https://grr.gred-clermont.fr/
labmirouse/software/WebPA/
Stack Focuser Michael Umorin https://imagej.nih.gov/ij/plugins/
stack-focuser.html
Axio-Vision software Zeiss https://www.zeiss.com/microscopy/
int/products/microscope-software/
axiovision.html
Zen software Zeiss https://www.zeiss.com/microscopy/
int/products/microscope-software/
zen.html
MetaMorph microscope automation and Imageanalysis
software
Molecular Devices https://www.moleculardevices.com/
products/cellular-imaging-systems/
acquisition-and-analysis-software/
metamorph-microscopy
OriginPro9.0.0 OriginLab Corporation, Northampton,
MA 01060 USA
https://www.originlab.com/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Thomas
Lecuit (thomas.lecuit@univ-amu.fr). Plasmids, FASTA sequences and transgenic fly lines generated in this study are all available on
request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The experiments were performed on Drosophila melanogaster embryos at the early stages of gastrulation (2h30 to 3h after egg
laying). We collected embryos from adult flies maintained under the standard lab conditions in plastic vials at 18C or 25Cwith yeast
food. Embryo collection was done in cages with agar plate made with apple juice, supplemented with yeast paste. Flies lay eggs on
these plates and embryos are filtered from the yeast paste by distilled water. Embryos are then treated with commercial bleach for
45 s and washed abundantly with distilled water. Embryos were staged under the binoculars and stuck on the coverslips. We usedCurrent Biology 29, 3370–3385.e1–e7, October 21, 2019 e2
Halocarbon oil 200 to cover embryos before live imaging. The embryos were prepared as described in [46]. Please refer to the Key
Resources Table for the details of the fly lines being used.
METHOD DETAILS
Transgenic lines
All fly constructs are listed in the Key Resources Table. 67-Gal4 (mat-4-GAL-VP16), nos-Gal4 and 15-Gal4 are ubiquitous, maternally
supplied, Gal4 drivers. Germline clones for Gg1N159 and RhoGEF2l(2)04291 were made using the FLP-DFS system [80].
SqhPa- Dp114RhoGEF expression vectors were generated using a SqhPa-sqh::mCherry modified vector (kind gift from A.Martin),
a pCasper vector containing a sqh (MyoII RLC, CG3595) minimal promoter. A PhiC31 attB sequence was inserted downstream of the
white gene of the SqhP vector into AfeI restriction site to perform PhiC31 site specific transgenesis. To build SqhPa- Dp114RhoGEF
plasmids, ORF of sqh::mCherry was replaced by the one of Dp114RhoGEF (CG10188) using 2 ESTs as matrices (RE42026 and
RE33026) to build a WT sequence (Genebank: NP_609977). Dp114RhoGEF was then tagged either N- or C-terminally by mEGFP
with a SGGGGS flexible aa linker in between. SqhPa- Dp114RhoGEF (CG10188) -shRNAR Resistant and SqhPa- eGFP::
Dp114RhoGEF (CG10188) -shRNAR Resistant were built by introducing silent point mutations to the codons of the 21bp targeted
by the shRNA TRIP 41579 (CACGAGACAGACAATGGATTA to CAtGAaACtGAtAAcGGtTTA). All recombinant expression vectors
were verified by sequence (Genewiz) and were sent to BestGene Incorporate for PhiC31 site specific mediated insertion into
attP2 (3L, 68A4). FASTA sequences of these vectors are available on request.
Fly genetics
F1 progeny (embryos) were analyzed for following crosses:
Figure 1A
; Ubi-GFP::AniRBD/Cyo ; Sqh-Sqh::mCh/ Sqh-Sqh::mCh (Females) X ; Ubi-GFP::AniRBD/Cyo ; Sqh-Sqh::mCh/ Sqh-Sqh::mCh
(Males)
Figures 1B–1D
;{mata4-GAL-VP16}/+;Ubi-GFP::AniRBD/+ (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}/+;Ubi-GFP::AniRBD/UAS-RhoGEF2 shRNA (Females) X y1 sc v1;;UAS-RhoGEF2 shRNA (Males)
Figure 1E
; endo-a-Catenin::YFP, Sqh-sqh::mCherry/+ (Females) X y[*] w[67c23] (Males)
y w hsflp / +;FRTG13 ovoD/ FRTG13 RhoGEF2l(2)04291; endo-a-Catenin::YFP, Sqh-sqh::mCherry/+ (Females) X y w hsflp / FRTG13
RhoGEF2l(2)04291/Cyo,Twist-Gal4,UAS-GFP;+/+ (Males)
Figure 1F
;; Sqh-sqh::GFP/+ (Females) X y[*] w[67c23] (Males)
y w hsflp / +;FRTG13 ovoD/ FRTG13 RhoGEF2l(2)04291; Sqh-sqh::GFP/+ (Females) X y w hsflp / FRTG13 RhoGEF2l(2)04291/Cyo;+/+
(Males)
Figure 2A
;Sqh-Sqh::mCh/ Sqh-Sqh::mCh;RhoGEF2-GFP::RhoGEF2/ RhoGEF2-GFP::RhoGEF2 (Females) X
;Sqh-Sqh::mCh/ Sqh-Sqh::mCh;RhoGEF2-GFP::RhoGEF2/ RhoGEF2-GFP::RhoGEF2 (Males)
Figure 2B
;{mata4-GAL-VP16}, UAS-EB1::GFP/Cyo; UASp-RhoGEF2::RFP/+ (Females) X ;Sp/Cyo ; UASp-RhoGEF2::RFP/ UASp-
RhoGEF2::RFP (Males)
Figures 2C–2G
;{mata4-GAL-VP16}/{mata4-GAL-VP16};RhoGEF2-GFP::RhoGEF2/RhoGEF2-GFP::RhoGEF2 (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}/{mata4-GAL-VP16};RhoGEF2-GFP::RhoGEF2/RhoGEF2-GFP::RhoGEF2 (Females) X ;;UASt-CtaQ303L/TM3
(Males)
;{mata4-GAL-VP16}/UAS-Cta shRNA ;RhoGEF2-GFP::RhoGEF2/RhoGEF2-GFP::RhoGEF2 (Females) X ;UAS-Cta shRNA/ UAS-
Cta shRNA;RhoGEF2-GFP::RhoGEF2/ RhoGEF2-GFP::RhoGEF2 (Males)e3 Current Biology 29, 3370–3385.e1–e7, October 21, 2019
Figure 2H
;{mata4-GAL-VP16}, UAS-EB1::GFP/Cyo (Females) X y[*] w[67c23 (Males)
;{mata4-GAL-VP16}, UAS-EB1::GFP/Cyo (Females) X ;;UAS- CtaQ303L/Tm3 (Males)
Figures 3A and 3B
;{mata4-GAL-VP16}/+; (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}/UAS- Dp114RhoGEF shRNA; (Females) X y1 sc v1; UAS- Dp114RhoGEF shRNA; (Males)
Figures 3C and 3D
;{mata4-GAL-VP16},Sqh-GFP::utABD,Sqh-Sqh::mKate/+; (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16},Sqh-GFP::utABD,Sqh-Sqh::mKate/ UAS- Dp114RhoGEF shRNA; (Females) X y1 sc v1; UAS-
Dp114RhoGEF shRNA; (Males)
Figure 3F
w;{mata4-GAL-VP16}/+; (Females) X y[*] w[67c23] (Males)
w;{mata4-GAL-VP16}/ UAS- Dp114RhoGEF shRNA; (Females) X y1 sc v1; UAS- Dp114RhoGEF shRNA/UAS- Dp114RhoGEF
shRNA; (Males)
w; ;{mata4-GAL-VP16}/ UAS- Dp114RhoGEF shRNA; Sqh- Dp114RhoGEF shRNA R/+ (Females) X y1 sc v1; UAS-
Dp114RhoGEF shRNA/UAS- Dp114RhoGEF shRNA; (Males)
Figures 4A–4C
;{mata4-GAL-VP16}/+;Ubi-GFP::AniRBD/+ (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}/ UAS- Dp114RhoGEF shRNA;Ubi-GFP::AniRBD/+ (Females) X y1 sc v1; UAS- Dp114RhoGEF shRNA/ UAS-
Dp114RhoGEF shRNA; (Males)
Figures 4D–4F, S3C, and S3F–S3H
;{mata4-GAL-VP16}, Sqh-Sqh::mCh,Ecad::GFP/+ (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}, Sqh-Sqh::mCh,Ecad::GFP/UAS- Dp114RhoGEF shRNA (Females) X y1 sc v1; UAS- Dp114RhoGEF shRNA/
UAS- Dp114RhoGEF shRNA; (Males)
Figures 4G–4K
;Ecad::GFP, Sqh-Sqh::mCh/ Ecad::GFP, Sqh-Sqh::mCh; (Females) X ;Ecad::GFP, Sqh-Sqh::mCh/ Ecad::GFP, Sqh-Sqh::mCh;
(Males)
;Ecad::GFP, Sqh-Sqh::mCh/ Ecad::GFP, Sqh-Sqh::mCh; Sqh- Dp114RhoGEF / Sqh- Dp114RhoGEF (Females) X ;Ecad::GFP,
Sqh-Sqh::mCh/ Ecad::GFP, Sqh-Sqh::mCh; Sqh- Dp114RhoGEF / Sqh- Dp114RhoGEF (Males)
Figures 5A–5F
;{mata4-GAL-VP16}/+; Ubi-GFP::AniRBD/+ (Females) X y[*] w[67c23] (Males)
y w hsflp / +;FRTG13 ovoD/ FRTG13 Gg1N159;Ubi-GFP::AniRBD/+ (Females) X w;FRTG13 Gg1N159/Cyo, ftz LacZ (Males)
;{mata4-GAL-VP16}/UASt-Gb13F#20; Ubi-GFP::AniRBD/UASt-Gg1#15 (Females) X ;UASt-Gb13F#20/ UASt-Gb13F#20;UASt-
Gg1#15/ UASt-Gg1#15 (Males)
Figures 5G–5I
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/+; (Females) X y[*] w[67c23] (Males)
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/ UASt-Gb13F#20;+/ UASt-Gg1#15 (Females) X ;UASt-Gb13F#20/ UASt-
Gb13F#20;UASt-Gg1#15/ UASt-Gg1#15 (Males)
Figures 6A–6C
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/+;15-Gal4/+ (Females) X y[*] w[67c23] (Males)
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/ UASt-Gb13F#20, UAS-Yellow shRNA;15-Gal4/ UASt-Gg1#15 (Females) X
;UASt-Gb13F#20, UAS-Yellow shRNA /UASt-Gb13F#20, UAS-Yellow shRNA; UASt-Gg1#15/UASt-Gg1#15 (Males)
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/ UASt-Gb13F#20, UAS- Dp114RhoGEF shRNA;15-Gal4/ UASt-Gg1#15
(Females) X ;UASt-Gb13F#20, UAS- Dp114RhoGEF shRNA /UASt-Gb13F#20, UAS- Dp114RhoGEF shRNA; UASt-Gg1#15/UASt-
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Figure 7A
w; Sqh-Sqh::mCh/Sqh-Sqh::mCh; Sqh-eGFP:: Dp114RhoGEF (Nter)/ Sqh-eGFP:: Dp114RhoGEF (Nter) (Females) X w; Sqh-
Sqh::mCh/Sqh-Sqh::mCh; Sqh-eGFP:: Dp114RhoGEF (Nter)/ Sqh-eGFP:: Dp114RhoGEF (Nter) (Males)
Figures 7B, S5B, and S5C
;; UASp-GAP43::mCherry, nanos-Gal4/Sqh-eGFP:: Dp114RhoGEF (Nter) (Females) X ;;Sqh-eGFP:: Dp114RhoGEF (Nter)/Sqh-
eGFP:: Dp114RhoGEF (Nter) (Males)
Figures 7D–7G and S6F
;;Sqh-eGFP:: Dp114RhoGEF (Nter)/+ (Females) X ;;Sqh-eGFP:: Dp114RhoGEF (Nter)/ Sqh-eGFP:: Dp114RhoGEF (Nter) (Males)
y w hsflp / +;FRTG13 ovoD/ FRTG13 Gg1N159;Sqh-eGFP:: Dp114RhoGEF (Nter) /+ (Females) X ;FRTG13 Gg1N159 /Cyo; Sqh-
eGFP:: Dp114RhoGEF (Nter)/ Sqh-eGFP:: Dp114RhoGEF (Nter) (Males)
w ;UASt-Gb13F#20/+; UASt-Gg1#15/Sqh-eGFP:: Dp114RhoGEF (Females) X ;UASt-Gb13F#20/ UASt-Gb13F#20;UASt-Gg1#15/
UASt-Gg1#15 (Males)
Figures S1A–S1C
w[*]; P{w[+mC] = mChFP-Rho1}21/+; Ubi-GFP::AniRBD/+ (Females) X y[*] w[67c23] (Males)
Figures S2A and S2B
y[*] w[67c23] (Females) X y[*] w[67c23] (Males)
Figures S2C and S2D
;Ecad::GFP, Sqh-Sqh::mCh/Ecad::GFP, Sqh-Sqh::mCh; (Females) X ;Ecad::GFP, Sqh-Sqh::mCh/Ecad::GFP, Sqh-Sqh::mCh;
(Males)
Figures S2E–S2G
;{mata4-GAL-VP16};Ubi-GFP::AniRBD/TM6 (Females) X y[*] w[67c23] (Males)
Figure S3B
;{mata4-GAL-VP16}/+; Sqh-eGFP:: Dp114RhoGEF R (Nter)/+ (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}/ UAS- Dp114RhoGEF shRNA; Sqh-eGFP:: Dp114RhoGEF shRNA R (Nter)/+ (Females) X y1 sc v1; UAS-
Dp114RhoGEF shRNA/UAS- Dp114RhoGEF shRNA; (Males)
Figure S3D
;{mata4-GAL-VP16}, Sqh-Sqh::mCh,Ecad::GFP/+ (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}, Sqh-Sqh::mCh,Ecad::GFP/UAS- Dp114RhoGEF shRNA (Females) X y1 sc v1; UAS- Dp114RhoGEF shRNA/
UAS- Dp114RhoGEF shRNA; (Males)
;{mata4-GAL-VP16}, Sqh-Sqh::mCh,Ecad::GFP/UAS- Dp114RhoGEF shRNA; Sqh- Dp114RhoGEF shRNAR/+ (Females) X y1 sc
v1; UAS- Dp114RhoGEF shRNA/UAS- Dp114RhoGEF shRNA; (Males)
Figures S4A–S4C
;{mata4-GAL-VP16}/+;Ubi-GFP::AniRBD/+ (Females) X y[*] w[67c23] (Males)
;{mata4-GAL-VP16}/ UAS- Dp114RhoGEF shRNA ; Ubi-GFP::AniRBD/UAS-RhoGEF2 shRNA (Females) X ;UAS- Dp114RhoGEF
shRNA/ UAS- Dp114RhoGEF shRNA;UAS-RhoGEF2 shRNA/ UAS-RhoGEF2 shRNA (Males)
Figures S4D–S4F
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/+; (Females) X y[*] w[67c23] (Males)
w;{mata4-GAL-VP16},Sqh-Sqh::mCh,Ecad::GFP/ UAS- Dp114RhoGEF shRNA; UAS-RhoGEF2 shRNA/+ (Females) X ;UAS-
Dp114RhoGEF shRNA/ UAS- Dp114RhoGEF shRNA;UAS-RhoGEF2 shRNA/ UAS-RhoGEF2 shRNA (Males)
Figure S5A
w;; Sqh-eGFP:: Dp114RhoGEF (Nter)/ Sqh-eGFP:: Dp114RhoGEF (Nter) (Females) X w;; Sqh-eGFP:: Dp114RhoGEF (Nter)/ Sqh-
eGFP:: Dp114RhoGEF (Nter) (Males)e5 Current Biology 29, 3370–3385.e1–e7, October 21, 2019
w;; Sqh- Dp114RhoGEF::GFP (Cter)/ Sqh- Dp114RhoGEF::GFP (Cter) (Females) X w;; Sqh- Dp114RhoGEF::GFP (Cter Sqh-
Dp114RhoGEF::GFP (Cter) (Males)RT-qPCR experiment
CG10188 shRNA (BL41579) knock-down efficiency was estimated by measuring endogenous mRNA level using RT-qPCR. Total
RNA extraction from 100 gastrulating embryos from maternal knockdown of CG10188 compared to {mata4-GAL-VP16} embryos
was performed using the Direct-zol RNA miniprep kit (Zymo Research, R2050). Retro-transcription was performed with the Super-
script IV VILO (Invitrogen, 11766050) according to the manufacturer’s protocol including a DNase I treatment to remove genomic
DNA contamination. Real-time PCR was performed on a CFX96 QPCR detection system (Bio-RAD) using TaqMan Fast Advanced
Master Mix (Life technologies) with the following TaqMan probes, following classical TaqMan protocol:
d CG10188: Dm01811075_m1 = probe located in E2 (exon 2-3 boundary, 1210 / GenBank NM_001273659, amplicon = 57bp).
d RPl32: House-keeping gene reference: Dm02151827_g1: (exon 2-3 boundary, 377 / GenBank NM_001144655, amplicon =
72bp)
d RPII140: House-keeping gene: Dm02134593_g1 (exon 2-3 boundary, 2347 / GenBank NM_001300394, amplicon = 78bp)
d Act42A: House-keeping gene: Dm02362162_g1 (one exon, 1439 / GenBank NM_078901, amplicon = 108bp)
RT-qPCR conditions were as follows: 50 for 2min; 95 for 10min; 40 cycles [95C for 15 s and 60C for 1min]. Analyses were per-
formed in duplicate from three independent RNA preparations. Beforehand, the three house keeping genes (Rpl32, RPlII40 and
Act42A) were compared to verify absence of any variation between samples (not shown). Transcript levels were first normalized
to the house keeping gene RPI32; and then to the control group. DDCq method was used to estimate relative amounts using the
Bio-RAD CFX Maestro software.
Antibody generation
To generate specific antibodies for Gb13F, peptides corresponding to the amino-terminal region and internal region of the Gb13F
protein were commercially synthesized and used to immunize rabbits (Eurogentec). The peptide sequences employed were as
follows: MNELDSLRQEAESLK (aa 1-15) and CKQTFPGHESDINAVT (aa 218-233). Polyclonal anti-Gb13F antibodies affinity purified
against the immunizing peptide were then tested for specificity in western blots and immunostainings. Lysates from dechorionated
embryos were prepared in 10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA; 0.5% NP-40 supplemented with HALT Protease/
Phosphatase Inhibitor Mix (Life Technologies) and 0.2M PMSF (Sigma). Samples were denatured, reduced, separated by SDS-
PAGE and transferred to PVDF membranes. After blocking, blots were incubated with polyclonal antibody (2mg/mL) with or without
preincubation of antibody with 200 mg/ml of immunizing/affinity purified peptide. A band of the expected molecular weight (43 kD)
was present in the western blot and was abolished when the antibody was preincubated with the immunizing peptide. Similarly,
the signal observed in subsequent immunofluorescence labelings was abolished when the antibody was preincubated with the
immunizing peptide.
Immunofluorescence
Methanol-heat fixation [81] was used for embryos labeled with rabbit anti-Gb13F (1:20, as described above), mouse anti-b catenin
(1:100, DSHB), mouse anti-Neurotactin (1:50, DSHB). A chicken anti-GFP antibody (1:1000, Aves Labs) was used in embryos ex-
pressing GFP:: Dp114RhoGEF to amplify the signal in fixed embryos. Secondary antibodies (Invitrogen) were used at 1:500. Fixed
samples (using Aqua-Poly mount, Polysciences) were imaged under a confocal microscope (LSM 780, Carl Zeiss) using a Plan Apo-
chromat 40x/1.4 NA oil immersion objective.
Bright field imaging
Standard techniques were used to immobilize embryos for imaging. Bright-field time-lapse images were collected on an inverted
microscope (Zeiss) and a programmable motorized stage to record different positions over time (Mark&Find module from Zeiss).
The system was run with AxioVision software (Zeiss) and allowed the acquisition of time-lapse datasets in wild-type or mutant em-
bryos. Images were acquired every 2 min for 40 min post dorsal movement of the posterior pole cells. The extent of elongation was
measured by tracking the distance between the pole cells and the posterior pole at each time point and normalized to the total length
of the embryo.
Embryo viability test
40 freshly hatched females and males were incubated at 25C for 4 days in each experimental conditions (Control, Dp114RhoGEF
shRNA andDp114RhoGEF shRNA, Sqh-Dp114RhoGEF shRNAR). For egg collection, flies were given a fresh apple juice agar plate to
lay eggs for 4 hours. Eggs were then counted and incubated at 25C for 2 days. The total number of emerging larva was counted and
plotted in percentage as a function of viability.Current Biology 29, 3370–3385.e1–e7, October 21, 2019 e6
Embryo injection
Microtubule depolymerization was carried out by injecting Colcemid (500mg/ml in water, 234109-M, Merck) in y[*] w[67c23] or Endo-
Cad::GFP, Sqh::mCh embryos during the fast phase of cellularization. Subsequently, embryos were filmed at the onset of germ-band
extension on a Nikon Roper spinning disc Eclipse Ti invertedmicroscope using a 100X_1.4 N.A. oil-immersion objective or on a Zeiss
inverted bright field microscope.
Image acquisition
Embryos were prepared as described before [46]. Timelapse imaging was done from stage 6 during 15 to 30 min depending on the
experiment, on a Nikon Roper spinning disc Eclipse Ti inverted microscope using a 100X_1.4 N.A. oil-immersion objective or a
40X _1.25 N.A. water-immersion (for cell-intercalation measurement) at 22C. The system acquires images using the Meta-Morph
software. For medial and junctional intensity measurements, 10 to 18 Z sections (depending on the experimental conditions),
0.5mm each, were acquired every 15 s. Laser power was measured and kept constant across all experiments.
Image analysis
All image processing was done in imageJ/Fiji free software. For all quantifications for medial and junctional Rho1-GTP and Myo-II,
maximum-intensity z-projection of slices was used, followed by a first background subtraction using the rolling ball tool (radius 50
pixels4mm) and a second subtraction where mean cytoplasmic intensity value measured on the projected stack was subtracted
to the same image. Cell outlines were extracted from spinning disk confocal images of Ecad::GFP or Rho1-GTP using the Tissue
Analyzer software [79] from B.Aigouy (IBDM, France). The Ecad-GFP resulting outlines were then dilated by 2 pixels on either side
of the junction (5-pixel-wide lines) and used as a junctional mask on the MyoII::mCherry channel. Medial-apical area was obtained
by shrinking individual cell mask by 4 pixels to exclude any contribution of junctional signal (ImageJ/Fiji macro from G. Kale [8], COS
Heidelberg). Medial and junctional Myo-II and Rho1-GTP values were mean intensities calculated in these two non-overlapping cell
areas.
For planar polarity analysis, junctional masks described previously were used to extract for each junction the mean pixel intensity
and orientation. Intensities were averaged for all junctions in each angular range. Amplitude of polarity was then calculated as a ratio
between signal intensity measured at vertical junctions (75-90 angular range) over intensity measured at transverse junctions (0-15
angular range).
Tomeasure the number of T1 transitions, Tissue Analyzer software. Segmentation was automatically performed on Utr::GFP chan-
nel by the plugin and corrected by the experimenter. Tracked cells present in the field of view during a period of 10min were then
analyzed for T1 events. T1 events were automatically detected by the plugin and checked manually to prevent false detections.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics
Errors bars are SEM unless otherwise indicated. Statistical significance was determined and P values calculated with a non-para-
metric Mann–Whitney U test or a Kolmogorov-Smirnov two-sample test in OriginPro9. The experiments were not randomized,
and the investigators were not blinded to allocation during experiments and outcome assessment.
DATA AND CODE AVAILABILITY
This study did not generate new datasets and code.e7 Current Biology 29, 3370–3385.e1–e7, October 21, 2019
